ACTRN12622001037796招募中未知
TIPTOE - Investigating Peripheral T cell Tolerance in Colorectal Cancer
Peter MacCallum Cancer Centre0 个研究点目标入组 25 人开始时间: 2022年7月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1. Subjects must have voluntarily provided written informed consent for the study.
- •2. Subjects must be at least 18 years of age at the time of consent.
- •3. Subject must have histologically confirmed or suspected colorectal adenocarcinoma.
- •4. Subjects must have stage IV disease based on the AJCC Cancer Staging Manual 8th edition.
- •5. Subjects must be undergoing surgical resection of their primary tumour at the Peter
- •MacCallum Cancer Centre as part of their routine oncological care.
排除标准
- •1. Subjects unable to voluntarily provide written informed consent.
- •2. Subjects with stage I-III colorectal cancer.
- •3. Any medical or psychosocial reason that in the opinion of the investigator would make
- •the subject inappropriate for the study.
研究者
相似试验
已完成
不适用
An initial study to determine the T lymphocyte response in seriously ill COVID-19 patients: An observational study in Pune, IndiaCTRI/2021/03/032028Dr D Y Patil Vidyapeeth Pune137
已完成
不适用
A pilot study to characterize T cell responses in young children after influenza infectio10047438influenzaNL-OMON33577niversitair Medisch Centrum Utrecht125
招募中
不适用
Evaluation of Transplant-reactive T cells for the Prediction or Diagnosis of Transplant Rejection in Kidney Transplant Recipients (TreaT-Assay)T86.10T86.11T86.12T86.19DRKS00028707Charité Campus Virchow-Klinikum185
进行中（未招募）
1 期
Cell based treatment in combination with checkpoint inhibitors for ovarian-, fallopian tube and primary peritoneal cancer.EUCTR2017-002179-24-DKCenter for Cancer Immune Therapy6
进行中（未招募）
Unknown
nderstanding how the immune system responds to repeated malaria infectionsP. falciparum malariaInfections and InfestationsISRCTN85988131niversity of Oxford22